Michael J.
- Country
- Sweden
- Department
- Memory Clinic
Research Overview
- A Phase 1, First-in-Human Study to Evaluate the Safety and Pharmacokinetics of RO7812653 in Patients with Early Symptomatic Alzheimer’s Disease
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia
- Efficacy and Safety Evaluation of Lecanemab in Early Alzheimer's Disease: A Placebo-Controlled, Double-Blind, Parallel-Group Study with Open-Label Extension
Data & Insights
Has run more than one trial at 73 of 120 partner sites.
Specializations
Early-Stage Alzheimer's Research
The investigator specializes in studying therapeutic interventions for early Alzheimer's disease, with particular focus on innovative treatment approaches for patients displaying initial symptoms.
- Early-stage disease progression monitoring
- Clinical Dementia Rating assessments
- Novel therapeutic compounds evaluation
Their work encompasses comprehensive evaluation of cognitive function changes in early-stage patients.
Cognitive Impairment Studies
Focused on investigating treatments for mild cognitive impairment related to Alzheimer's disease, the investigator conducts research on interventions targeting early cognitive decline.
- Cognitive assessment methodologies
- Disease progression markers
- Therapeutic response monitoring
Their research extends to evaluating cognitive outcomes in preclinical and mild cognitive impairment stages.
Advanced Therapeutic Approaches
The investigator explores innovative treatment modalities including immunotherapy and targeted molecular interventions for Alzheimer's disease.
- Tau-targeted therapies
- Immunological interventions
- Long-term therapeutic efficacy
Their work includes evaluation of novel compounds targeting specific pathological mechanisms of Alzheimer's disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.